Managed Healthcare Executive gives C-suite executives in health plans and provider organizations news and strategies for ...

Results come after positive results from a trial among people with idiopathic pulmomary disease.

Lung macrophages play a pivotal role in diseases like idiopathic pulmonary fibrosis. Two types of macrophages—the white blood ...

Panelists discuss how emerging, better-tolerated oral therapies for idiopathic pulmonary fibrosis (IPF) and progressive ...

Panelists discuss recent trial data demonstrating that a novel agent not only slows lung function decline but also delays ...

Chinese scientists have developed a novel nanotherapy known as biomimetic extracellular vesicle spherical nucleic acids ...

Pulmonary fibrosis (PF) is a progressive interstitial lung disease (ILD) characterised by excessive fibrotic tissue deposition in the pulmonary parenchyma. The term "pulmonary" refers to the lungs ...

Neither pulmonary fibrosis nor emphysema currently has a cure. However, treatments can help manage symptoms. Options for both conditions include oxygen therapy and, in severe cases, a lung transplant.

Pulmonary fibrosis (PF) is a type of interstitial lung disease that causes lung tissue to scar, thicken, and stiffen. It can make breathing difficult and interfere with oxygen absorption into the ...

Pulmonary fibrosis is a lung disease that occurs when lung tissue becomes damaged and scarred. This thickened, stiff tissue makes it more difficult for your lungs to work properly.